Search

Your search keyword '"Camiciottoli, Gianna"' showing total 202 results
Start Over Author "Camiciottoli, Gianna"
202 results on '"Camiciottoli, Gianna"'

1. Profiling severe asthma: Any relevance for age? An analysis from Severe Asthma Network Italy (SANI) cohort

Author

Brussino, Luisa, Calabrese, Cecilia, Camiciottoli, Gianna, Carpagnano, Giovanna E., Centanni, Stefano, Corsico, Angelo G., Costantino, Maria T., Crimi, Claudia, D'adda, Alice, D'alo, Simona, D'amato, Maria, Del Giacco, Stefano, Di Marco, Fabiano, Facciolongo, Nicola C., Latorre, Manuela, Nettis, Eustachio, Nucera, Eleonora, Passalacqua, Giovanni, Pelaia, Girolamo, Pini, Laura, Ricciardi, Luisa, Richeldi, Luca, Ridolo, Erminia, Santus, Pierachille, Scichilone, Nicola, Scioscia, Giulia, Spadaro, Giuseppe, Spanevello, Antonio, Tarsia, Paolo, Caminati, Marco, Marcon, Alessandro, Vaia, Rachele, Senna, Gianenrico, Maule, Matteo, Marchetti, Pierpaolo, Miotti, Jessica, Argentino, Giuseppe, Blasi, Francesco, Canonica, Giorgio W., Heffler, Enrico M., Paggiaro, Pierluigi, Vianello, Andrea, and Guarnieri, Gabriella

Published
2024
Full Text
View/download PDF

4. Severe Asthma Network Italy Definition of Clinical Remission in Severe Asthma: A Delphi Consensus

Author

Canonica, Giorgio Walter, Blasi, Francesco, Carpagnano, Giovanna Elisiana, Guida, Giuseppe, Heffler, Enrico, Paggiaro, Pierluigi, Allegrini, Chiara, Antonelli, Andrea, Aruanno, Arianna, Bacci, Elena, Bagnasco, Diego, Beghè, Bianca, Bonavia, Marco, Bonini, Matteo, Brussino, Luisa, Caiaffa, Maria Filomena, Calabrese, Cecilia, Camiciottoli, Gianna, Caminati, Marco, Caruso, Cristiano, Cavallini, Mirta, Chieco Bianchi, Fulvia, Conte, Maria Elisabetta, Corsico, Angelo Guido, Cosmi, Lorenzo, Costantino, Mariateresa, Costanzo, Giulia, Crivellaro, Mariaangiola, D'Alò, Simona, D'Amato, Mariella, Detoraki, Aikaterini, Di Proietto, Maria Carmela, Facciolongo, Nicola Cosimo, Ferri, Sebastian, Fierro, Vincenzo, Foschino, Maria Pia, Latorre, Manuela, Lombardi, Carlo, Macchia, Luigi, Milanese, Manlio, Montagni, Marcello, Parazzini, Elena Maria, Parente, Roberta, Passalacqua, Giovanni, Patella, Vincenzo, Pelaia, Girolamo, Pini, Laura, Puggioni, Francesca, Ricciardi, Luisa, Ridolo, Erminia, Rolo, Joyce, Scichilone, Nicola, Scioscia, Giulia, Senna, Gianenrico, Solidoro, Paolo, Varricchi, Gilda, Vianello, Andrea, Yacoub, Mona Rita, and Yang, Baoran

Published
2023
Full Text
View/download PDF

5. Asthma remission one, none and one-hundred thousand: the relevance of the patient's view.

Author

Bonini, Matteo, Barbaglia, Simona, Camiciottoli, Gianna, Del Giacco, Stefano, Di Marco, Fabiano, Matucci, Andrea, Micheletto, Claudio, Papi, Alberto, Pasqualetti, Patrizio, Pelaia, Girolamo, Ricciardolo, Fabio Luigi Massimo, Rogliani, Paola, Senna, Gianenrico, Triggiani, Massimo, Vancheri, Carlo, and Canonica, Giorgio Walter

Subjects
PATIENTS' attitudes, THERAPEUTIC alliance, PATIENT preferences, DISEASE management, INDIVIDUALIZED medicine
Abstract

Objective: Achieving remission in severe asthma holds paramount importance in elevating patient quality of life and reducing both individual and societal burdens associated with this chronic condition. This study centers on identifying pivotal patient-relevant endpoints through standardized, reproducible methods, while also developing a patient-centric definition of remission, essential for effective disease management. Methods: A discrete choice experiment (DCE) was conducted to assess patients' perceptions on the four primary criteria for defining severe asthma remission, as outlined by the SANI survey. Additionally, it investigated the correlation between these perceptions and improvements in the doctor-patient therapeutic alliance during treatment decision-making. Results: 249 patients (70% aged between 31–60, 59% women and 82% without other pathologies requiring corticosteroids) prioritize the use of oral corticosteroids (OCS, 48%) and the Asthma Control Test (ACT, 27%) in defining their condition, ranking these above lung function and exacerbations. This preference for OCS stems from its direct role in treatment, tangible tracking, immediate symptom relief, and being a concrete measure of disease severity compared to the less predictable and quantifiable exacerbations. Conclusions: This study explores severe asthma remission from patients' perspectives using clinician-evaluated parameters. The DCE revealed that most patients highly value OCS and the ACT, prefer moderate improvement, and avoid cortisone cycles. No definitive preference was found for lung function status. Integrating patient-reported information with professional insights is crucial for effective management and future research. Personalized treatment plans focusing on patient preferences, adherence, and alternative therapies aim to achieve remission and enhance quality of life. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

6. Severe asthma: One disease and multiple definitions

Author

Guarnieri, Gabriella, Patella, Vincenzo, Maria Pia, Foschino Barbaro, Carpagnano, Giovanna Elisiana, Colle, Anna del, Scioscia, Giulia, Gerolamo, Pelaia, Puggioni, Francesca, Racca, Francesca, Favero, Elisabetta, Iannacone, Sandra, Savi, Eleonora, Montagni, Marcello, Camiciottoli, Gianna, Allegrini, Chiara, Lombardi, Carlo, Spadaro, Giuseppe, Detoraki, Caterina, Menzella, Francesco, Galeone, Carla, Ruggiero, Patrizia, Yacoub, Monna Rita, Berti, Alvise, Scichilone, Nicola, Durante, Carmen, Costantino, Maria Teresa, Roncallo, Chiara, Braschi, Mariachiara, D’Adda, Alice, Ridolo, Erminia, Triggiani, Massimo, Parente, Roberta, Maria, D’Amato, Verrillo, Maria Vittoria, Rolla, Giovanni, Brussino, Luisa, Frazzetto, Agata Valentina, Cristina, Zappa Maria, Lilli, Marianna, Crimi, Nunzio, Bonavia, Marco, Corsico, Angelo Guido, Grosso, Amelia, Del Giacco, Stefano, Deidda, Margherita, Ricciardi, Luisa, Isola, Stefania, Cicero, Francesca, Amato, Giuliana, Vita, Federica, Spanevello, Antonio, Pignatti, Patrizia, Cherubino, Francesca, Visca, Dina, Massimo Ricciardolo, Fabio Luigi, Anna Carriero, Vitina Maria, Bertolini, Francesca, Santus, Pierachille, Barlassina, Roberta, Airoldi, Andrea, Guida, Giuseppe, Eleonora, Nucera, Aruanno, Arianna, Rizzi, Angela, Caruso, Cristiano, Colantuono, Stefania, Senna, Gianenrico, Caminati, Marco, Arcolaci, Alessandra, Vianello, Andrea, Bianchi, Fulvia Chieco, Marchi, Maria Rita, Centanni, Stefano, Luraschi, Simone, Ruggeri, Silvia, Rinaldo, Rocco, Parazzini, Elena, Calabrese, Cecilia, Flora, Martina, Cosmi, Lorenzo, Di Pietro, Linda, Maggi, Enrico, Pini, Laura, Macchia, Luigi, Di Bona, Danilo, Richeldi, Luca, Condoluci, Carola, Fuso, Leonello, Bonini, Matteo, Farsi, Alessandro, Carli, Giulia, Montuschi, Paolo, Santini, Giuseppe, Conte, Maria Elisabetta, Turchet, Elisa, Barbetta, Carlo, Mazza, Francesco, D’Alo, Simona, Pucci, Stefano, Caiaffa, Maria Filomena, Minenna, Elena, D'Elia, Luciana, Pasculli, Carlo, Viviano, Vittorio, Tarsia, Paolo, Rolo, Joyce, Di Proietto, Mariacarmela, Lo Cicero, Salvatore, Bagnasco, Diego, Paggiaro, Pierluigi, Latorre, Manuela, Folli, Chiara, Testino, Elisa, Bassi, Arianna, Milanese, Manlio, Heffler, Enrico, Manfredi, Andrea, Riccio, Anna Maria, De Ferrari, Laura, Blasi, Francesco, Canevari, Rikki Frank, Canonica, Giorgio Walter, and Passalacqua, Giovanni

Published
2021
Full Text
View/download PDF

7. Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life

Author

Guarnieri, Gabriella, Patella, Vincenzo, Maria Pia, Foschino Barbaro, Carpagnano, Elisiana, Colle, Anna del, Scioscia, Giulia, Gerolamo, Pelaia, Paggiaro, Pierluigi, Latorre, Manuela, Puggioni, Francesca, Racca, Francesca, Favero, Elisabetta, Iannacone, Sandra, Savi, Eleonora, Montagni, Marcello, Camiciottoli, Gianna, Allegrini, Chiara, Spadaro, Giuseppe, Detoraki, Caterina, Galeone, Carla, Ruggiero, Patrizia, Yacoub, Monna Rita, Berti, Alvise, Colombo, Gisella, Scichilone, Nicola, Durante, Carmen, Costantino, Maria Teresa, Roncallo, Chiara, Braschi, Mariachiara, Blasi, Francesco, D'Adda, Alice, Ridolo, Erminia, Triggiani, Massimo, Parente, Roberta, Maria, D'Amato, Verrillo, Maria Vittoria, Cristina, Zappa Maria, Lilli, Marianna, Crimi, Nunzio, Bonavia, Marco, Corsico, Angelo Guido, Grosso, Amelia, Del Giacco, Stefano, Deidda, Margherita, Ricciardi, Luisa, Isola, Stefania, Cicero, Francesca, Amato, Giuliana, Vita, Federica, Spanevello, Antonio, Pignatti, Patrizia, Cherubino, Francesca, Visca, Dina, Aletti, Eleonora, Massimo Ricciardolo, Fabio Luigi, Anna Carriero, Vitina Maria, Bertolini, Francesca, Santus, Pierachille, Barlassina, Roberta, Airoldi, Andrea, Guida, Giuseppe, Eleonora, Nucera, Aruanno, Arianna, Rizzi, Angela, Caruso, Cristiano, Colantuono, Stefania, Arcolaci, Alessandra, Vianello, Andrea, Bianchi, Fulvia Chieco, Marchi, Maria Rita, Centanni, Stefano, Luraschi, Simone, Ruggeri, Silvia, Rinaldo, Rocco, Parazzini, Elena, Calabrese, Cecilia, Flora, Martina, Cosmi, Lorenzo, Di Pietro, Linda, Maggi, Enrico, Pini, Laura, Macchia, Luigi, Di Bona, Danilo, Richeldi, Luca, Condoluci, Carola, Fuso, Leonello, Bonini, Matteo, Farsi, Alessandro, Carli, Giulia, Montuschi, Paolo, Santini, Giuseppe, Conte, Maria Elisabetta, Turchet, Elisa, Barbetta, Carlo, Mazza, Francesco, D'Alo, Simona, Pucci, Stefano, Caiaffa, Maria Filomena, Minenna, Elena, D'Elia, Luciana, Pasculli, Carlo, Viviano, Vittorio, Tarsia, Paolo, Rolo, Joyce, Di Proietto, Mariacarmela, Lo Cicero, Salvatore, Bagnasco, Diego, Povero, Massimiliano, Pradelli, Lorenzo, Brussino, Luisa, Rolla, Giovanni, Caminati, Marco, Menzella, Francesco, Heffler, Enrico, Canonica, Giorgio Walter, Senna, Gianenrico, Milanese, Manlio, Lombardi, Carlo, Bucca, Caterina, Manfredi, Andrea, Canevari, Rikki Frank, and Passalacqua, Giovanni

Published
2021
Full Text
View/download PDF

8. TRITRIAL: The Impact of Fixed Triple Therapy with Beclometasone/Formoterol/Glycopyrronium on Health Status and Adherence in Chronic Obstructive Pulmonary Disease in an Italian Context of Real Life

Author

Richeldi,Luca, Schino,Pietro, Bargagli,Elena, Ricci,Alberto, Rocca,Alberto, Marchesani,Francesca, Pennisi,Alfio, Camiciottoli,Gianna, D'Amato,Maria, Macagno,Francesco, Scaffidi Argentina,Ulrica, Ingrassia,Eleonora, Piraino,Alessio, Richeldi,Luca, Schino,Pietro, Bargagli,Elena, Ricci,Alberto, Rocca,Alberto, Marchesani,Francesca, Pennisi,Alfio, Camiciottoli,Gianna, D'Amato,Maria, Macagno,Francesco, Scaffidi Argentina,Ulrica, Ingrassia,Eleonora, and Piraino,Alessio

Abstract

Luca Richeldi,1 Pietro Schino,2 Elena Bargagli,3 Alberto Ricci,4 Alberto Rocca,5 Francesca Marchesani,6 Alfio Pennisi,7 Gianna Camiciottoli,8,9 Maria D’Amato,10 Francesco Macagno,1 Ulrica Scaffidi Argentina,11 Eleonora Ingrassia,11 Alessio Piraino11 1Division of Pulmonary Medicine, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy; 2Miulli Hospital, Acquaviva Delle Fonti, Bari, Italy; 3Respiratory Diseases Unit, Department of Medical and Surgical Sciences, Neuro Sciences, Siena University Hospital, Siena, Italy; 4Department of Medical-Surgical Sciences and Translational Medicine, Via di Grottarossa 1035, Sapienza University of Rome, Rome, Italy; 5Department of Respiratory Medicine, Bellaria Hospital, Bologna, Italy; 6Division of Pneumology, Ospedale di Macerata, Macerata, Italy; 7Department of Respiratory Medicine, Hospital Clinic “Casa di Cura Riabilitativa Calaciura”, Catania, Italy; 8Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy; 9Department of Cardiothoracovascular, Careggi University Hospital, Firenze, Italy; 10UOSD Malattie Respiratorie ”Federico II”, Ospedale Monaldi, Napoli, 80131, Italy; 11Medical Affairs, Chiesi Italia S.p.A, Parma, ItalyCorrespondence: Ulrica Scaffidi Argentina, Chiesi Italia S.P.A, Via Giacomo Chiesi 1, Parma, 43122, Italy, Tel +39 0521 1689690 ; +39 346 82 61 074, Email u.scaffidiargentina@chiesi.comPurpose: The TRITRIAL study assessed the effects of beclometasone dipropionate/formoterol fumarate/glycopyrronium (BDP/FF/G) fixed combination in patients with chronic obstructive pulmonary disease (COPD) in a real-world setting, focusing on patient’s experience and perspective through the use of patients reported outcomes.Patients and Methods: TRITRIAL was a multicenter, prospective, observational study conducted on patients with moderate-severe C

Published
2024

9. TRITRIAL: The Impact of Fixed Triple Therapy with Beclometasone/Formoterol/Glycopyrronium on Health Status and Adherence in Chronic Obstructive Pulmonary Disease in an Italian Context of Real Life

Author

Richeldi, Luca, Schino, Pietro, Bargagli, Elena, Ricci, Alberto, Rocca, Alberto, Marchesani, Francesca, Pennisi, Alfio, Camiciottoli, Gianna, D'Amato, Maria, Macagno, Francesco, Scaffidi Argentina, Ulrica, Ingrassia, Eleonora, Piraino, Alessio, Richeldi, Luca (ORCID:0000-0001-8594-1448), Richeldi, Luca, Schino, Pietro, Bargagli, Elena, Ricci, Alberto, Rocca, Alberto, Marchesani, Francesca, Pennisi, Alfio, Camiciottoli, Gianna, D'Amato, Maria, Macagno, Francesco, Scaffidi Argentina, Ulrica, Ingrassia, Eleonora, Piraino, Alessio, and Richeldi, Luca (ORCID:0000-0001-8594-1448)

Abstract

Purpose: The TRITRIAL study assessed the effects of beclometasone dipropionate/formoterol fumarate/glycopyrronium (BDP/FF/G) fixed combination in patients with chronic obstructive pulmonary disease (COPD) in a real-world setting, focusing on patient's experience and perspective through the use of patients reported outcomes. Patients and methods: TRITRIAL was a multicenter, prospective, observational study conducted on patients with moderate-severe COPD treated with BDP/FF/G fixed therapy for 12 months. The main objective was to evaluate the impact of BDP/FF/G on health status through the COPD Assessment Test (CAT) score. Additional assessments included adherence and satisfaction, measured by the TAI-10/12 questionnaire and a specifically designed eight-item questionnaire, quality of life through the EQ-5D-5L test, sleep quality through the COPD and Asthma Sleep Impact Scale (CASIS), as well as safety and disease-related outcomes. Results: Data from 655 patients were analyzed in the study. The mean total CAT score significantly improved (from 22.8 at baseline to 18.1 at 6 months and 16.5 at 12 months; p < 0.0001), as well as all the eight CAT sub-items, which decreased on average by 0.5-0.9 points during the study. Adherence and usability of the inhaler also improved during the study, with a decrease in poor compliance (from 30.1% to 18.3%) and an increase in good compliance (from 51.8% to 58.3%) according to the TAI score. Patients also benefited from significantly improved quality of life (EQ Index from 0.70 to 0.80; EQ-5D VAS score from 55.1 to 63.1) and sleep quality (CASIS score from 41.1 to 31.8). Finally, patients reported a significant reduction in exacerbation during the study. Conclusion: TRITRIAL showed that the BDP/FF/G fixed combination is effective and safe in patients with moderate-severe COPD and poorly controlled disease, improving patients' HRQoL, sleep quality, adherence and inhaler usability and reducing COPD symptoms and the risk of exacerbati

Published
2024

10. Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI)

Author

Canonica, Giorgio Walter, Blasi, Francesco, Paggiaro, Pierluigi, Senna, Gianenrico, Passalacqua, Giovanni, Spanevello, Antonio, Aliberti, Stefano, Bagnasco, Diego, Bonavia, Marco, Bonini, Matteo, Brussino, Luisa, Bucca, Caterina, Caiaffa, Maria F., Calabrese, Cecilia, Camiciottoli, Gianna, Caminati, Marco, Carpagnano, Giovanna E., Caruso, Cristiano, Centanni, Stefano, Conte, Maria E., Corsico, Angelo G., Cosmi, Lorenzo, Costantino, Maria T., Crimi, Nunzio, D’Alò, Simona, D'Amato, Maria, Del Giacco, Stefano, Farsi, Alessandro, Favero, Elisabetta, Foschino Barbaro, Maria P., Guarnieri, Gabriella, Guida, Giuseppe, Latorre, Manuela, Lo Cicero, Salvatore, Lombardi, Carlo, Macchia, Luigi, Mazza, Francesco, Menzella, Francesco, Milanese, Manlio, Montagni, Marcello, Montuschi, Paolo, Nucera, Eleonora, Parente, Roberta, Patella, Vincenzo, Pelaia, Girolamo, Pini, Laura, Puggioni, Francesca, Ricciardi, Luisa, Ricciardolo, Fabio L.M., Richeldi, Luca, Ridolo, Erminia, Rolla, Giovanni, Santus, Pierachille, Scichilone, Nicola, Spadaro, Giuseppe, Vianello, Andrea, Viviano, Vittorio, Yacoub, Mona R., Zappa, Maria C., and Heffler, Enrico

Published
2020
Full Text
View/download PDF

11. TRITRIAL: The Impact of Fixed Triple Therapy with Beclometasone/Formoterol/Glycopyrronium on Health Status and Adherence in Chronic Obstructive Pulmonary Disease in an Italian Context of Real Life

Author

Richeldi, Luca, primary, Schino, Pietro, additional, Bargagli, Elena, additional, Ricci, Alberto, additional, Rocca, Alberto, additional, Marchesani, Francesca, additional, Pennisi, Alfio, additional, Camiciottoli, Gianna, additional, D'Amato, Maria, additional, Macagno, Francesco, additional, Scaffidi Argentina, Ulrica, additional, Ingrassia, Eleonora, additional, and Piraino, Alessio, additional

Published
2024
Full Text
View/download PDF

12. The Severe Asthma Network in Italy: Findings and Perspectives

Author

Barbuto, Sarah, Bradicich, Matteo, Camiciottoli, Gianna, Caminati, Marco, Colombo, Giselda, Costantino, Maria Teresa, Crimi, Nunzio, Crivellaro, Mariangiola, D’Adda, Alice, D’Amato, Mariella, Favero, Elisabetta, Foschino, Maria Pia, Galeone, Carla, Guarnieri, Gabriella, Lombardi, Carlo, Parente, Roberta, Passalacqua, Giovanni, Patella, Vincenzo, Puggioni, Francesca, Ridolo, Erminia, Rolla, Giovanni, Savi, Eleonora, Scichilone, Nicola, Solidoro, Paolo, Spadaro, Giuseppe, Heffler, Enrico, Blasi, Francesco, Latorre, Manuela, Menzella, Francesco, Paggiaro, Pierluigi, Pelaia, Girolamo, Senna, Gianenrico, and Canonica, Giorgio Walter

Published
2019
Full Text
View/download PDF

13. Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry

Author

Aliberti, Stefano, Bagnasco, Diego, Barbuto, Sarah, Camiciottoli, Gianna, Caminati, Marco, Colombo, Giselda, Costantino Maria, Teresa, Crimi, Claudia, Crivellaro, Mariangiola, D'Amato, Mariella, Favero, Elisabetta, Foschino Maria, Pia, Guarnieri, Gabriella, Latorre, Manuela, Lombardi, Carlo, Menzella, Francesco, Patella, Vincenzo, Puggioni, Francesca, Ridolo, Erminia, Rolla, Giovanni, Savi, Eleonora, Scichilone, Nicola, Solidoro, Paolo, Spadaro, Giuseppe, Triggiani, Massimo, Canonica, Giorgio Walter, Colombo, Giorgio Lorenzo, Bruno, Giacomo Matteo, Di Matteo, Sergio, Martinotti, Chiara, Blasi, Francesco, Bucca, Caterina, Crimi, Nunzio, Paggiaro, Pierluigi, Pelaia, Girolamo, Passalaqua, Giovanni, Senna, Gianenrico, and Heffler, Enrico

Published
2019
Full Text
View/download PDF

15. TRITRIAL study - TRIple Therapy in Real life: Impact on Adherence and HeaLth status in COPD patients in Italy.

Author

Richeldi, Luca, primary, Schino, Pietro, additional, Bargagli, Elena, additional, Ricci, Alberto, additional, Rocca, Alberto, additional, Marchesani, Francesca, additional, Pennisi, Alfio, additional, Camiciottoli, Gianna, additional, D'Amato, Mariella, additional, Macagno, Francesco, additional, Scaffidi Argentina, Ulrica, additional, Garavelli, Elena, additional, Ingrassia, Eleonora, additional, and Piraino, Alessio, additional

Published
2023
Full Text
View/download PDF

16. The Impact of Extrafine Beclometasone/Formoterol/Glycopyrronium on Sleep disturbance in Chronic Obstructive Pulmonary Disease (COPD) in an Italian Context of Real Life: The TRITRIAL Study.

Author

Richeldi, Luca, primary, Schino, Pietro, additional, Bargagli, Elena, additional, Ricci, Alberto, additional, Rocca, Alberto, additional, Marchesani, Francesca, additional, Pennisi, Alfio, additional, Camiciottoli, Gianna, additional, D'Amato, Mariella, additional, Macagno, Francesco, additional, Scaffidi Argentina, Ulrica, additional, Garavelli, Elena, additional, Ingrassia, Eleonora, additional, and Piraino, Alessio, additional

Published
2023
Full Text
View/download PDF

18. Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry

Author

Giorgio Walter Canonica, Giorgio Lorenzo Colombo, Giacomo Matteo Bruno, Sergio Di Matteo, Chiara Martinotti, Francesco Blasi, Caterina Bucca, Nunzio Crimi, Pierluigi Paggiaro, Girolamo Pelaia, Giovanni Passalaqua, Gianenrico Senna, Enrico Heffler, Aliberti Stefano, Bagnasco Diego, Barbuto Sarah, Camiciottoli Gianna, Caminati Marco, Colombo Giselda, Costantino Maria Teresa, Crimi Claudia, Crivellaro Mariangiola, D'Amato Mariella, Favero Elisabetta, Foschino Maria Pia, Guarnieri Gabriella, Latorre Manuela, Lombardi Carlo, Francesco Menzella, Patella Vincenzo, Puggioni Francesca, Ridolo Erminia, Rolla Giovanni, Savi Eleonora, Scichilone Nicola, Solidoro Paolo, Spadaro Giuseppe, and Triggiani Massimo

Subjects
Immunologic diseases. Allergy, RC581-607
Abstract

Background: Asthma is one of the most common non-communicable respiratory diseases, affecting about 6% of the general population. Severe asthma, even if afflicts a minority of asthmatics, drives the majority of costs of the disease. The aim of this study is to create a pharmacoeconomic model to predict the costs of corticosteroid-related adverse events in severe asthmatics and applying it to the first published epidemiologic data from the Severe Asthma Network in Italy (SANI) registry. Methods: The analysis was conducted from the perspective of the Italian National Healthcare System (INHS). Model inputs, derived from literature, included: asthma epidemiology data, frequency of adverse events, percentage of severe asthma treated with OCS and adverse event cost (Diagnosis-Related Group (DRG) national tariffs). We estimated costs per different patient groups: non-asthma controls, mild/moderate and severe asthmatics. Final results report estimated direct cost per patient and total direct cost for overall target population, showing economic impact related to corticosteroid complication. Results: Based on epidemiological data input, in Italy, asthmatic subjects resulted about 3,999,600, of which 199,980 with severe asthma. The number of patients with severe asthma OCS-treated was estimated at 123,988. Compared to the non-asthma control cohort and to that with moderate asthma annual cost per severe asthmatic patient resulted respectively about €892 and €606 higher, showing a corticosteroids shadow cost ranging from 45% to 30%.Applying the cost per patient to the target population identified for Italy, the budget impact model estimated a total annual cost related to OCS-related adverse events of €242.7 million for severe asthmatics. In respect with non-asthmatic and moderate population, an incremental expenditure of about € 110.6 million and €75.2, respectively, were shown. Conclusions: Our study provides the first estimates of additional healthcare costs related to corticosteroid induced adverse events in severe asthma patient. Budget impact model results highlighted the relevant economic impact of OCS-related adverse events in severe asthma patients. The future extrapolation of additional data from SANI registry will support the development of a model to investigate the role of corticosteroids sparing drugs. Keywords: Severe asthma, Oral corticosteroids, Adverse events, Pharmacoeconomy, Costs, Diabetes, Glaucoma, Obesity, Bone fracture, Chronic kidney disease

Published
2019
Full Text
View/download PDF

22. Lung vascular changes as biomarkers of severity in systemic sclerosis–associated interstitial lung disease

Author

Bruni, Cosimo, primary, Occhipinti, Mariaelena, additional, Pienn, Michael, additional, Camiciottoli, Gianna, additional, Bartolucci, Maurizio, additional, Bosello, Silvia Laura, additional, Payer, Christian, additional, Bálint, Zoltán, additional, Larici, Anna Rita, additional, Tottoli, Alessandra, additional, Tofani, Lorenzo, additional, De Lorenzis, Enrico, additional, Lepri, Gemma, additional, Bellando-Randone, Silvia, additional, Spinella, Amelia, additional, Giuggioli, Dilia, additional, Masini, Francesco, additional, Cuomo, Giovanna, additional, Lavorini, Federico, additional, Colagrande, Stefano, additional, Olschewski, Horst, additional, and Matucci-Cerinic, Marco, additional

Published
2022
Full Text
View/download PDF

23. Do COPD subtypes really exist? COPD heterogeneity and clustering in 10 independent cohorts

Author

Castaldi, Peter J, Benet, Marta, Petersen, Hans, Rafaels, Nicholas, Finigan, James, Paoletti, Matteo, Marike Boezen, H, Vonk, Judith M, Bowler, Russell, Pistolesi, Massimo, Puhan, Milo A, Anto, Josep, Wauters, Els, Lambrechts, Diether, Janssens, Wim, Bigazzi, Francesca, Camiciottoli, Gianna, Cho, Michael H, Hersh, Craig P, Barnes, Kathleen, Rennard, Stephen, Boorgula, Meher Preethi, Dy, Jennifer, Hansel, Nadia N, Crapo, James D, Tesfaigzi, Yohannes, Agusti, Alvar, Silverman, Edwin K, and Garcia-Aymerich, Judith

Published
2017
Full Text
View/download PDF

24. “Adrenaline junkie”: a case report of repeated use of epinephrine

Author

Salvati, Lorenzo, primary, Allegrini, Chiara, additional, Piccardi, Benedetta, additional, Lombardo, Ivano, additional, Ciambellotti, Lorenzo, additional, Rizzello, Sonia, additional, Palumbo, Vanessa, additional, Lavorini, Federico, additional, Camiciottoli, Gianna, additional, and Parronchi, Paola, additional

Published
2022
Full Text
View/download PDF

25. Lung vascular changes as biomarkers of severity in systemic sclerosis–associated interstitial lung disease.

Author

Bruni, Cosimo, Occhipinti, Mariaelena, Pienn, Michael, Camiciottoli, Gianna, Bartolucci, Maurizio, Bosello, Silvia Laura, Payer, Christian, Bálint, Zoltán, Larici, Anna Rita, Tottoli, Alessandra, Tofani, Lorenzo, Lorenzis, Enrico De, Lepri, Gemma, Bellando-Randone, Silvia, Spinella, Amelia, Giuggioli, Dilia, Masini, Francesco, Cuomo, Giovanna, Lavorini, Federico, and Colagrande, Stefano

Subjects
BIOMARKERS, DIGITAL image processing, INTERSTITIAL lung diseases, SYSTEMIC scleroderma, RETROSPECTIVE studies, ACQUISITION of data, PULMONARY function tests, MEDICAL records, DESCRIPTIVE statistics, RESEARCH funding, COMPUTED tomography
Abstract

Objectives It has recently become possible to assess lung vascular and parenchymal changes quantitatively in thoracic CT images using automated software tools. We investigated the vessel parameters of patients with SSc, quantified by CT imaging, and correlated them with interstitial lung disease (ILD) features. Methods SSc patients undergoing standard of care pulmonary function testing and CT evaluation were retrospectively evaluated. CT images were analysed for ILD patterns and total pulmonary vascular volume (PVV) extents with Imbio lung texture analysis. Vascular analysis (volumes, numbers and densities of vessels, separating arteries and veins) was performed with an in-house developed software. A threshold of 5% ILD extent was chosen to define the presence of ILD, and commonly used cut-offs of lung function were adopted. Results A total of 79 patients [52 women, 40 ILD, mean age 56.2 (s. d. 14.2) years, total ILD extent 9.5 (10.7)%, PVV/lung volume % 2.8%] were enrolled. Vascular parameters for total and separated PVV significantly correlated with functional parameters and ILD pattern extents. SSc-associated ILD (SSc-ILD) patients presented with an increased number and volume of arterial vessels, in particular those between 2 and 4 mm of diameter, and with a higher density of arteries and veins of <6 mm in diameter. Considering radiological and functional criteria concomitantly, as well as the descriptive trends from the longitudinal evaluations, the normalized PVVs, vessel numbers and densities increased progressively with the increase/worsening of ILD extent and functional impairment. Conclusion In SSc patients CT vessel parameters increase in parallel with ILD extent and functional impairment, and may represent a biomarker of SSc-ILD severity. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

26. Severe asthma: One disease and multiple definitions

Author

Bagnasco, Diego, primary, Paggiaro, Pierluigi, additional, Latorre, Manuela, additional, Folli, Chiara, additional, Testino, Elisa, additional, Bassi, Arianna, additional, Milanese, Manlio, additional, Heffler, Enrico, additional, Manfredi, Andrea, additional, Riccio, Anna Maria, additional, De Ferrari, Laura, additional, Blasi, Francesco, additional, Canevari, Rikki Frank, additional, Canonica, Giorgio Walter, additional, Passalacqua, Giovanni, additional, Guarnieri, Gabriella, additional, Patella, Vincenzo, additional, Maria Pia, Foschino Barbaro, additional, Carpagnano, Giovanna Elisiana, additional, Colle, Anna del, additional, Scioscia, Giulia, additional, Gerolamo, Pelaia, additional, Puggioni, Francesca, additional, Racca, Francesca, additional, Favero, Elisabetta, additional, Iannacone, Sandra, additional, Savi, Eleonora, additional, Montagni, Marcello, additional, Camiciottoli, Gianna, additional, Allegrini, Chiara, additional, Lombardi, Carlo, additional, Spadaro, Giuseppe, additional, Detoraki, Caterina, additional, Menzella, Francesco, additional, Galeone, Carla, additional, Ruggiero, Patrizia, additional, Yacoub, Monna Rita, additional, Berti, Alvise, additional, Scichilone, Nicola, additional, Durante, Carmen, additional, Costantino, Maria Teresa, additional, Roncallo, Chiara, additional, Braschi, Mariachiara, additional, D’Adda, Alice, additional, Ridolo, Erminia, additional, Triggiani, Massimo, additional, Parente, Roberta, additional, Maria, D’Amato, additional, Verrillo, Maria Vittoria, additional, Rolla, Giovanni, additional, Brussino, Luisa, additional, Frazzetto, Agata Valentina, additional, Cristina, Zappa Maria, additional, Lilli, Marianna, additional, Crimi, Nunzio, additional, Bonavia, Marco, additional, Corsico, Angelo Guido, additional, Grosso, Amelia, additional, Del Giacco, Stefano, additional, Deidda, Margherita, additional, Ricciardi, Luisa, additional, Isola, Stefania, additional, Cicero, Francesca, additional, Amato, Giuliana, additional, Vita, Federica, additional, Spanevello, Antonio, additional, Pignatti, Patrizia, additional, Cherubino, Francesca, additional, Visca, Dina, additional, Massimo Ricciardolo, Fabio Luigi, additional, Anna Carriero, Vitina Maria, additional, Bertolini, Francesca, additional, Santus, Pierachille, additional, Barlassina, Roberta, additional, Airoldi, Andrea, additional, Guida, Giuseppe, additional, Eleonora, Nucera, additional, Aruanno, Arianna, additional, Rizzi, Angela, additional, Caruso, Cristiano, additional, Colantuono, Stefania, additional, Senna, Gianenrico, additional, Caminati, Marco, additional, Arcolaci, Alessandra, additional, Vianello, Andrea, additional, Bianchi, Fulvia Chieco, additional, Marchi, Maria Rita, additional, Centanni, Stefano, additional, Luraschi, Simone, additional, Ruggeri, Silvia, additional, Rinaldo, Rocco, additional, Parazzini, Elena, additional, Calabrese, Cecilia, additional, Flora, Martina, additional, Cosmi, Lorenzo, additional, Di Pietro, Linda, additional, Maggi, Enrico, additional, Pini, Laura, additional, Macchia, Luigi, additional, Di Bona, Danilo, additional, Richeldi, Luca, additional, Condoluci, Carola, additional, Fuso, Leonello, additional, Bonini, Matteo, additional, Farsi, Alessandro, additional, Carli, Giulia, additional, Montuschi, Paolo, additional, Santini, Giuseppe, additional, Conte, Maria Elisabetta, additional, Turchet, Elisa, additional, Barbetta, Carlo, additional, Mazza, Francesco, additional, D’Alo, Simona, additional, Pucci, Stefano, additional, Caiaffa, Maria Filomena, additional, Minenna, Elena, additional, D'Elia, Luciana, additional, Pasculli, Carlo, additional, Viviano, Vittorio, additional, Tarsia, Paolo, additional, Rolo, Joyce, additional, Di Proietto, Mariacarmela, additional, and Lo Cicero, Salvatore, additional

Published
2021
Full Text
View/download PDF

32. Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life

Author

Bagnasco, Diego, primary, Povero, Massimiliano, additional, Pradelli, Lorenzo, additional, Brussino, Luisa, additional, Rolla, Giovanni, additional, Caminati, Marco, additional, Menzella, Francesco, additional, Heffler, Enrico, additional, Canonica, Giorgio Walter, additional, Paggiaro, Pierluigi, additional, Senna, Gianenrico, additional, Milanese, Manlio, additional, Lombardi, Carlo, additional, Bucca, Caterina, additional, Manfredi, Andrea, additional, Canevari, Rikki Frank, additional, Passalacqua, Giovanni, additional, Guarnieri, Gabriella, additional, Patella, Vincenzo, additional, Maria Pia, Foschino Barbaro, additional, Carpagnano, Elisiana, additional, Colle, Anna del, additional, Scioscia, Giulia, additional, Gerolamo, Pelaia, additional, Latorre, Manuela, additional, Puggioni, Francesca, additional, Racca, Francesca, additional, Favero, Elisabetta, additional, Iannacone, Sandra, additional, Savi, Eleonora, additional, Montagni, Marcello, additional, Camiciottoli, Gianna, additional, Allegrini, Chiara, additional, Spadaro, Giuseppe, additional, Detoraki, Caterina, additional, Galeone, Carla, additional, Ruggiero, Patrizia, additional, Yacoub, Monna Rita, additional, Berti, Alvise, additional, Colombo, Gisella, additional, Scichilone, Nicola, additional, Durante, Carmen, additional, Costantino, Maria Teresa, additional, Roncallo, Chiara, additional, Braschi, Mariachiara, additional, Blasi, Francesco, additional, D'Adda, Alice, additional, Ridolo, Erminia, additional, Triggiani, Massimo, additional, Parente, Roberta, additional, Maria, D'Amato, additional, Verrillo, Maria Vittoria, additional, Cristina, Zappa Maria, additional, Lilli, Marianna, additional, Crimi, Nunzio, additional, Bonavia, Marco, additional, Corsico, Angelo Guido, additional, Grosso, Amelia, additional, Del Giacco, Stefano, additional, Deidda, Margherita, additional, Ricciardi, Luisa, additional, Isola, Stefania, additional, Cicero, Francesca, additional, Amato, Giuliana, additional, Vita, Federica, additional, Spanevello, Antonio, additional, Pignatti, Patrizia, additional, Cherubino, Francesca, additional, Visca, Dina, additional, Aletti, Eleonora, additional, Massimo Ricciardolo, Fabio Luigi, additional, Anna Carriero, Vitina Maria, additional, Bertolini, Francesca, additional, Santus, Pierachille, additional, Barlassina, Roberta, additional, Airoldi, Andrea, additional, Guida, Giuseppe, additional, Eleonora, Nucera, additional, Aruanno, Arianna, additional, Rizzi, Angela, additional, Caruso, Cristiano, additional, Colantuono, Stefania, additional, Arcolaci, Alessandra, additional, Vianello, Andrea, additional, Bianchi, Fulvia Chieco, additional, Marchi, Maria Rita, additional, Centanni, Stefano, additional, Luraschi, Simone, additional, Ruggeri, Silvia, additional, Rinaldo, Rocco, additional, Parazzini, Elena, additional, Calabrese, Cecilia, additional, Flora, Martina, additional, Cosmi, Lorenzo, additional, Di Pietro, Linda, additional, Maggi, Enrico, additional, Pini, Laura, additional, Macchia, Luigi, additional, Di Bona, Danilo, additional, Richeldi, Luca, additional, Condoluci, Carola, additional, Fuso, Leonello, additional, Bonini, Matteo, additional, Farsi, Alessandro, additional, Carli, Giulia, additional, Montuschi, Paolo, additional, Santini, Giuseppe, additional, Conte, Maria Elisabetta, additional, Turchet, Elisa, additional, Barbetta, Carlo, additional, Mazza, Francesco, additional, D'Alo, Simona, additional, Pucci, Stefano, additional, Caiaffa, Maria Filomena, additional, Minenna, Elena, additional, D'Elia, Luciana, additional, Pasculli, Carlo, additional, Viviano, Vittorio, additional, Tarsia, Paolo, additional, Rolo, Joyce, additional, Di Proietto, Mariacarmela, additional, and Lo Cicero, Salvatore, additional

Published
2021
Full Text
View/download PDF

35. Mepolizumab Effectiveness and Allergic Status in Real Life

Author

Sposato, Bruno, primary, Scalese, Marco, additional, Camiciottoli, Gianna, additional, Carpagnano, Giovanna Elisiana, additional, Pelaia, Corrado, additional, Santus, Pierachille, additional, Maniscalco, Mauro, additional, Corsico, Angelo, additional, Grosso, Amelia, additional, Baglioni, Stefano, additional, Murgia, Nicola, additional, Folletti, Ilenia, additional, Pelaia, Girolamo, additional, Masieri, Simonetta, additional, Cavaliere, Carlo, additional, Musarra, Antonino, additional, Bargagli, Elena, additional, Ricci, Alberto, additional, Latorre, Manuela, additional, Paggiaro, Pierluigi, additional, and Rogliani, Paola, additional

Published
2020
Full Text
View/download PDF

37. Quantitative analysis of pulmonary vasculature in systemic sclerosis at spirometry-gated chest CT

Author

Occhipinti, Mariaelena, primary, Bruni, Cosimo, additional, Camiciottoli, Gianna, additional, Bartolucci, Maurizio, additional, Bellando-Randone, Silvia, additional, Bassetto, Anna, additional, Cuomo, Giovanna, additional, Giuggioli, Dilia, additional, Ciardi, Giulia, additional, Fabbrizzi, Alessio, additional, Tomassetti, Sara, additional, Lavorini, Federico, additional, Pistolesi, Massimo, additional, Colagrande, Stefano, additional, and Matucci-Cerinic, Marco, additional

Published
2020
Full Text
View/download PDF

38. Mepolizumab effectiveness on small airway obstruction, corticosteroid sparing and maintenance therapy step-down in real life

Author

Sposato, Bruno, primary, Camiciottoli, Gianna, additional, Bacci, Elena, additional, Scalese, Marco, additional, Carpagnano, Giovanna Elisiana, additional, Pelaia, Corrado, additional, Santus, Pierachille, additional, Maniscalco, Mauro, additional, Masieri, Simonetta, additional, Corsico, Angelo, additional, Scichilone, Nicola, additional, Baglioni, Stefano, additional, Murgia, Nicola, additional, Folletti, Ilenia, additional, Bardi, Giulio, additional, Grosso, Amelia, additional, Cameli, Paolo, additional, Latorre, Manuela, additional, Musarra, Antonino, additional, Bargagli, Elena, additional, Ricci, Alberto, additional, Pelaia, Girolamo, additional, Paggiaro, Pierluigi, additional, and Rogliani, Paola, additional

Published
2020
Full Text
View/download PDF

39. Additional file 1: of Spirometric assessment of emphysema presence and severity as measured by quantitative CT and CT-based radiomics in COPD

Author

Mariaelena Occhipinti, Paoletti, Matteo, Bartholmai, Brian, Srinivasan Rajagopalan, Karwoski, Ronald, Nardi, Cosimo, Inchingolo, Riccardo, Larici, Anna, Camiciottoli, Gianna, Lavorini, Federico, Colagrande, Stefano, Brusasco, Vito, and Pistolesi, Massimo

Abstract

Theoretical background and description of ESI method (PDF 499 kb)

Published
2019
Full Text
View/download PDF

41. The Severe Asthma Network in Italy: Findings and Perspectives

Author

Heffler, Enrico, primary, Blasi, Francesco, additional, Latorre, Manuela, additional, Menzella, Francesco, additional, Paggiaro, Pierluigi, additional, Pelaia, Girolamo, additional, Senna, Gianenrico, additional, Canonica, Giorgio Walter, additional, Barbuto, Sarah, additional, Bradicich, Matteo, additional, Camiciottoli, Gianna, additional, Caminati, Marco, additional, Colombo, Giselda, additional, Costantino, Maria Teresa, additional, Crimi, Nunzio, additional, Crivellaro, Mariangiola, additional, D’Adda, Alice, additional, D’Amato, Mariella, additional, Favero, Elisabetta, additional, Foschino, Maria Pia, additional, Galeone, Carla, additional, Guarnieri, Gabriella, additional, Lombardi, Carlo, additional, Parente, Roberta, additional, Passalacqua, Giovanni, additional, Patella, Vincenzo, additional, Puggioni, Francesca, additional, Ridolo, Erminia, additional, Rolla, Giovanni, additional, Savi, Eleonora, additional, Scichilone, Nicola, additional, Solidoro, Paolo, additional, and Spadaro, Giuseppe, additional

Published
2019
Full Text
View/download PDF

42. Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry

Author

Canonica, Giorgio Walter, primary, Colombo, Giorgio Lorenzo, additional, Bruno, Giacomo Matteo, additional, Di Matteo, Sergio, additional, Martinotti, Chiara, additional, Blasi, Francesco, additional, Bucca, Caterina, additional, Crimi, Nunzio, additional, Paggiaro, Pierluigi, additional, Pelaia, Girolamo, additional, Passalaqua, Giovanni, additional, Senna, Gianenrico, additional, Heffler, Enrico, additional, Aliberti, Stefano, additional, Bagnasco, Diego, additional, Barbuto, Sarah, additional, Camiciottoli, Gianna, additional, Caminati, Marco, additional, Colombo, Giselda, additional, Costantino Maria, Teresa, additional, Crimi, Claudia, additional, Crivellaro, Mariangiola, additional, D'Amato, Mariella, additional, Favero, Elisabetta, additional, Foschino Maria, Pia, additional, Guarnieri, Gabriella, additional, Latorre, Manuela, additional, Lombardi, Carlo, additional, Menzella, Francesco, additional, Patella, Vincenzo, additional, Puggioni, Francesca, additional, Ridolo, Erminia, additional, Rolla, Giovanni, additional, Savi, Eleonora, additional, Scichilone, Nicola, additional, Solidoro, Paolo, additional, Spadaro, Giuseppe, additional, and Triggiani, Massimo, additional

Published
2019
Full Text
View/download PDF

43. Mepolizumab Effectiveness and Allergic Status in Real Life.

Author

Sposato, Bruno, Scalese, Marco, Camiciottoli, Gianna, Carpagnano, Giovanna Elisiana, Pelaia, Corrado, Santus, Pierachille, Maniscalco, Mauro, Corsico, Angelo, Grosso, Amelia, Baglioni, Stefano, Murgia, Nicola, Folletti, Ilenia, Pelaia, Girolamo, Masieri, Simonetta, Cavaliere, Carlo, Musarra, Antonino, Bargagli, Elena, Ricci, Alberto, Latorre, Manuela, and Paggiaro, Pierluigi

Subjects
PHENOTYPES, ASTHMATICS, NITRIC oxide, SEAFARING life, ASTHMA
Abstract

Background: It is not clear whether mepolizumab is differently effective in allergic and nonallergic severe eosinophilic asthmatics (SEA) in real life. Objective: We tested mepolizumab effectiveness in allergic/nonallergic SEA in real life. A strict criterion to identify the 2 phenotypes was used. Method: We retrospectively considered 134 consecutive patients divided into allergic, with a positivity to at least 1 allergen to prick tests and/or IgE values ≥100 UI/mL (severe allergic eosinophilic asthma [SAEA]; n: 97–72.4%), and nonallergic, with no prick test results and normal IgE levels <100 UI/mL (severe nonallergic eosinophilic asthma [SNAEA]; n: 37–27.6%). They had taken mepolizumab for at least 6 months. Results: After 10.9 ± 3.7 months, improvements in FEV1%, FEF25–75%, exacerbation numbers, blood eosinophil (BE) counts, fractional exhaled nitric oxide (FENO) (ppb), percentages of patients that stopped/reduced short-acting β2-agonists (SABAs) or oral corticosteroid (OC), observed after treatment, were similar in both groups. Only Asthma Control Test (ACT) increases were higher in SNAEA (8 [5–9]) than in SAEA (5 [2.5–8.5]; p = 0.016). However, no differences were found after treatment in percentages of subjects with ACT ≥20, as well as with FEV1 >80%, FEF25–75 >65%, exacerbations ≤2, BE <300 cells/µL, and FENO <25 ppb between SAEA and SNAEA. Besides, no significant relationships were found, comparing SNAEA with SAEA, for FEV1% (β = −0.110; p = 0.266), FEF25–75% (β = −0.228; p = 0.06), BE counts (β = −0.012; p = 0.918), FENO (β = 0.234; p = 0.085), ACT (β = 0.046; p = 0.660), and exacerbations (β = −0.070; p = 0.437). No different associations between lung function and SNAEA occurrence when compared to SAEA condition (FEV1 >80%: OR = 1.04 [95% CI: 0.43–2.55], p = 0.923; FEF25–75 >65%: OR = 0.41 [95% CI: 0.08–2.03], p = 0.272) were detected. Neither all other parameters, such as ACT >20 (OR = 0.73 [95% CI: 0.32–1.63], p = 0.440), presence of exacerbations (OR = 1.35 [95% CI: 0.55–3.27], p = 0.512), SABA discontinuation (OR = 1.16 [95% CI: 0.40–3.39], p = 0.790), and OC cessation/reduction (OR = 3.44 [95% CI: 0.40–29.27], p = 0.258), were differently associated with 1 or the other phenotype. Conclusion: Mepolizumab can be considered as a valid therapeutic choice for either allergic or nonallergic SEA in real life. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

44. Changes in transcutaneous oxygen partial pressure as an index of response to inhaled methacholine in asthmatic patients

Author

Fontana, Giovanni A., Cardellicchio, Salvatore, Camiciottoli, Gianna, Panuccio, Pasquale, and Boddi, Vieri

Subjects
Bronchial spasm -- Diagnosis, Bronchoconstrictor agents -- Measurement, Pulmonary gas exchange -- Measurement, Asthma -- Diagnosis, Health, Diagnosis, Measurement
Abstract

Bronchoconstriction and hypoxemia have been reported to occur during airway challenges, but the correlation between changes in forced expiratory volume in 1 s ([FEV.sub.1]) and transcutaneous oxygen partial pressure ([tcPo.sub.2]) [...]

Published
1993

Catalog

Books, media, physical & digital resources
See catalog results